Market Research Blog – Page 13305 – New Product Development

Rx-to-OTC Switches Market size is likely to surpass US$ 58 Billion by 2031

Rx-to-OTC switches refer to the transition from proven prescription drugs to nonprescription, OTC status. According to a report by Future Market Insights (FMI), the global Rx-to-OTC switches market was valued at US$ 33 Bn in 2020 and is predicted to expand at a CAGR of over 5% during the forecast period (2021–2031).

Scientifically, it is a rigorous and highly regulated process that allows consumers to purchase OTC access to a growing range of medicines. For a medicine to be granted under OTC status, it must comply with the regulatory standards associated with its efficacy, have a wide safety margin, and bolster labelling to ensure proper usage of the product.

The increasing prevalence of diseases with common self-treatable symptoms, such as cold and flu, headaches, allergies, and others has fuelled the demand for OTC drugs. Thus, growing sales of nonprescription drugs have pushed pharmaceutical companies to focus on Rx to OTC switches to meet customer needs thereby gaining high revenue in the market.

It was observed in 2020, Rx-to-OTC activity was driven by growing regulatory approvals and increased OTC sales. The COVID-19 outbreak has restricted patients to visit hospitals and clinics suffering from common illnesses. Consequently, delays in prescribed medication have shifted the customer preference towards the OTC drug consumption. As a result, the COVID 19 outbreak bolstered the demand for OTC products, which in turn has supported the adoption of Rx-to-OTC switches.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-9135

The Food and Drug Administration (FDA) introduced the non-prescription safe use regulatory expansion (NSURE) panel in 2013 that has supported a new wave of Rx-to-OTC switches, with a focus on creating conditions for switches in new therapeutic classes.

The introduction of the panel aimed to promote switches which had gained consumer attention, which in turn has aided the demand for the OTC drugs in the market.

Key Takeaways from Rx-to-OTC Switches Market Study

Allergy and respiratory drugs are anticipated to gain a revenue share of more than 25% with a CAGR of 5.7% owing to the rising prevalence of lifestyle-based ailments.
Retail pharmacies are anticipated to grow at a CAGR of 5.1% over the forecast period owing to the rise of e-commerce and the procurement of cost-effective medicines.
The U.K. holds the lead in Europe, holding a share of over 33% owing to the implementation of favorable government policies.
The U.S. will account for over 77% of the North America market by 2031, supported by a matured healthcare and pharmaceutical sector and favorable reimbursement policies.
China is the largest and fastest growing market in East Asia estimated to account for close to 49% of the global market, owing to the country’s large-scale pharmaceutical requirements.

Who is Winning?

Rx to OTC switches have led the pharmaceutical companies to shift focus from patients to consumers in terms of end users. In addition to strategic collaborations, acquisitions, expansion, product launches, agreements and research sponsorships are the key strategies adopted by manufacturers to expand their research and development (R&D) capabilities increasing sales in wider geographical base to strengthen product portfolios in the Rx-to-OTC switches market.

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-9135

Why Future Market Insights?

• Comprehensive analysis on evolving purchase pattern across different geographies
• Detailed insights of market segments and sub-segments for historical as well as forecast period
• A competitive analysis of prominent players and emerging players in the keyword market
• Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:

Future Market Insights,
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

Feminine Hygiene Products Market sales are likely to surpass US$ 54,189.6 Million by 2031

Government initiatives undertaken to spread awareness about women health and menstrual hygiene, besides brand consolidation strategies by leading producers and the adoption of modern lifestyles by women will push feminine hygiene products sales in the coming years.

According to the recent Future Market Insights (FMI) report, the global feminine hygiene products market value is estimated to surpass US$ 27.6 Bn in 2021, with a CAGR of 7.0% during the forecast period (2021-2031).

Around 49% of the global population is female and nearly 65% of them are aged between 15 and 65 years, thereby indicating a significant opportunity for manufacturers of feminine hygiene products.

Government organizations are focusing on women’s health and hygiene with the help of launch of various awareness programs and funding activities. These programs include detailed education about menstruation, puberty, and the advantages and health benefits of using hygiene products.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-13350

They are also providing sanitation kits to girls studying in government schools and colleges in rural areas, particularly in developing economies around the globe. For instance, in 2017, the Department of Education in KwaZulu-Natal (KZN) of South Africa set aside Rs 50 million to fund the distribution of sanitary towels and napkins to various schools in the region.

Additionally, rising female populations in countries such as India, Ghana, and Nigeria will create lucrative opportunities. Concerns regarding disposal, have resulted in the introduction of reusable menstrual cups. These cups are made from medical grade silicon or latex and cost between US$ 20 and US$ 50 per pack and can last for nearly five years. Such innovations will give tailwinds to growth registered in the market.

The impact of the ongoing COVID-19 pandemic on production of feminine products has been negligible despite short term disruptions of transportation and logistics.

Key Takeaways from Feminine Hygiene Products Market Study

Sanitary napkins are the largest and fastest growing segment accounting for nearly half of the market by 2031, with a CAGR of over 8%.
Supermarket are projected to account for over 22% of the global market by 2031. This is attributed to robust supply channels for consumer health products.
East Asia is the largest revenue-generating region for feminine hygiene products, with the China accounting for nearly 81% of the regional market in 2021.
Germany holds the lead in Europe, and is expected to accounting for over 18% of the market in 2031.
South Asia is the second most lucrative market after East Asia with India accounting for over 75% of the value share in 2031.

Who is Winning?

Some of the leading manufacturers of the feminine hygiene products market are focusing on mergers and acquisitions for global expansion. Thus, enhancing their market presence.

The key market players covered by FMI include Procter and Gamble, Johnson and Johnson, the Kimberly-Clark Corporation, Svenska Cellulosa Aktiebolaget SCA, Sanofi S.A, Lil-lets UK Limited, Ontex, Unicharm Corporation, Diva International Inc., and Edgewell Personal Care.

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-13350

Why Future Market Insights?

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:

Contact Us:

Whole Genome Amplification Market is projected to grow at about 8.5% CAGR during the forecast period 2021-2031

The global whole genome amplification market is estimated at around US$ 5.08 Bn by the end of 2031, as indicated by a recent report released by Future Market Insights. The global market for whole genome amplification will possibly expand at a CAGR of 7.9% during the forecast period, 2021-2031

A US-based team of researchers has recently developed a microfluidic device for isolating a genomic DNA, which is to be purified later. This DNA is sourced from individual cells and the device physically catches single cells using a micropillar array.

It also captures chromosomal DNA of these single cells post-extraction, which is later immobilized in the micropillar array so as to enable the process of isothermal amplification. The entire methodology is referred to as ‘on-chip cell capture and DNA extraction’.

As conventional single cell WGA is often prone to amplification biases, which may hold a significant influence on the accuracy of the data of single cell sequencing.

This drawback is foreseen to be overcome with the introduction of single cell on-chip WGA, resulting in reduced biases regarding amplification, offering an improved coverage of the genome. The team has used individual cancer cell genomes (human), sourced from the HeLa Cell Line.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-1873

WGA has been a crucial procedure that helps in DNA analysis from limited quantities of genomic DNA. The ease provided by various WGA kits available for the entire process has been driving the market over the years.

Increasing research activities will remain the key factor pushing the growth of whole genome amplification market over the next decade. Adoption of this process is expected to witness robust growth, predominantly among research institutes, hospitals, diagnostic centers, and forensic labs, as it offers an improved and advanced means of genome amplification and sequencing.

To increase the revenue share, molecular testing companies are focusing more on the development of advanced devices and kits such as WGA kits and complete WGA kits with advanced capabilities.

The global whole genome amplification market is estimated at around US$ 5.08 Bn by the end of 2031, as indicated by a recent report released by Future Market Insights. The global market for whole genome amplification will possibly expand at a CAGR of 7.9% during the forecast period, 2021-2031.

Single Cell WGA Continues to Bring in New Applications

Introduction of massively parallel single-cell genome sequencing is anticipated to offer a new dimension to the understanding of genetic diversities in complex biological systems.

Single cell WGA is a method used to examine the sequence information with the optimized next generation sequencing technologies, only from a single cell. This method is considered to be a powerful tool that helps to understand the ins and outs of genetics by bringing the entire genome structure to a cellular level.

Since this method offers a high-resolution view of the genomic sample, its adoption will continue to be on the rise in diverse biological fields such as microbiology, immunology, neurobiology, cancer research, and tissue mosaicism.

Single cell WGA also plays a crucial role in conveying new applications to the market, eventually pushing the market growth further through 2031.

The key players of the market, including GE Healthcare, Sygnis AG, Illumina, Inc., Merck KGaA, Thermo Fisher Scientific Inc., and Active Motif are inclined more towards strategic acquisitions and mergers.

They are also looking for distribution and collaboration agreements to help improve their product reach. It will also help them serve end users better, with diagnostic consulting and good laboratory practices. High price point may remain a major challenge for companies.

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-1873

Why Future Market Insights?

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:

Contact Us:

Insulin Pens Market is Rising at a Healthy CAGR of 4.4% between 2021 and 2031

According to Future Market Insights (FMI), the demand for insulin pens is expected to rise considerably in the coming decade, enabling the market to surpass a valuation of US$ 30,407.5 Mn by the end of 2021.

Insulin pens are used by diabetes patients to avoid problems including cardiovascular diseases that may arise from this lifestyle-based ailment. To overcome problems related to conventional methods of insulin administration, insulin pens make the process easier and faster.

According to the WHO, approximately 1.2 million deaths were caused due to diabetes in 2019 globally. To reduce the number of deaths or sufferings due to diabetes, the development of innovative techniques and products for the treatment and maintenance of diabetes is essential.

Type 2 diabetes cases are common, but it can be prevented or delayed by a healthy diet, consistent physical activity, maintaining a standard body weight and avoiding the use of tobacco. Diabetes can be treated or managed with medicines and regular checking and treatment. Increasing focus on innovative medical products and research are increasingly driving a transition towards insulin pen by diabetes patients.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-13518

Leading manufacturers in the insulin pen market are strengthening their market position through collaborations with various health and research organizations. Governments in developed and developing countries are actively taking initiatives to encourage innovative medical products.

For instance, in November 2020, Medtronic introduced CGM integrated smart insulin delivery pen to manage multiple daily dosage insulin injections. Similarly, Insulet expanded its offering of OmipodDASH into additional countries such as Sweden, Finland, Norway, and Denmark.

Key Takeaways from Insulin Pen Services Market Study

Reusable insulin pens are expected to account for over 49% the global market share by 2031, supported by a growing base of environment and cost-conscious consumers.
Hospital pharmacies will account for 33.8% of the market share in 2031. The soaring influx of patients for treatment and intensive care support supports growth.
The U.S. is projected to be the fastest-growing regional market with a CAGR of 5.6% through 2021-2031 owing to the matured healthcare sector of the country.
The U.K. and Germany are leading markets in Europe, accounting for more than 18% and 25% in 2021.
China is the largest and fastest growing market in East Asia, exhibiting a 4.7% CAGR through 2031.
Australia is leading the Oceania market, accounting for more than 85% of insulin pen revenues in 2021.

Who is Winning?

The global insulin pen market is set to expand due to the rising prevalence of type 1 and type 2 diabetes. Leading organizations within the market are set to focus on research and development to offer an early and precise diagnosis of the ailment, besides offering effective patient care.

Some of the leading players in the insulin pen market include but are not limited to NovoNordisk A/S, Sanofi, Eli Lilly, Diamesco Co., Ltd., BigFoot Biomedical, Inc, Medtronic plc, Emperra GmbH E-Health Technologies, YpsoMed AG, and DUKADA Aps.

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-13518

Why Future Market Insights?

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:

Contact Us:

Lipase Market Outlook, Current and Future Industry Landscape Analysis 2026

Growing prevalence of celiac disease and obesity has led to an upsurge in demand for lipase globally. In addition, surge in demand for production of detergents will continue to impact the global market growth of lipase. Future Market Insights states that the global market of lipase is projected to reflect a CAGR of 7.8% over the forecast period, 2017-2026.

Factors Fuelling Growth of the Global Market

Growth of the global lipase market is mainly bound to various micro-economic and macro-economic factors. Surge in consumption of the food products that are rich in carbohydrate and fatty food items has led to surge in health diseases such as abdominal discomfort, indigestion and bloating. In order to inhibit prevalence of these health diseases has led to surge in demand for lipase in the global market. In addition, increasing prevalence of high triglyceride, obesity and cholesterol will continue to impact the global market growth of lipase positively. World Health Organization in its recent report stated that 39% of adults aged 18 years and above reported overweight in 2016 whereas 13% were obese. As lipase breaks the fats into fatty acid and glycerol, possibilities of weight gains and obesity is reduced. The global market of lipase is projected to gain momentum bound to such factors during the forecast period.

Attributed to various industrial and health benefits, lipase continues to witness significant demand in various industries such as food industry, detergent industry and dairy industry. As application of lipase enhances the shelf life, texture and flavor of the food products, manufacturers are increasing using lipase during the food production process. In addition, increasing demand for hydrolyzing milk fat for the production of various dairy items will continue to rev up sales of lipase in the global market. Lipase continues to find application in coffee whiteners and cheese dairy products. Increasing application of lipase in coffee whitener offers creamy flavor and buttery texture in the toffees and caramel. Such factors are likely to impact the global market growth of lipase significantly throughout 2026.

Besides application in the dairy industry, lipase continues to witness robust demand in the detergent industry. Surge in need to remove the fatty residues and cleaning clogged drains has led to a surge in demand for lipase during the production of house cleaning products. Attributed to features that help in eradicating the fatty residue, manufacturers in the detergent industry are mainly looking for range of lipases including proteases and amylases. Application of these lipases will enable the manufacturers to offer cleaning products with improved efficiency. Further, the detergent industry, which is controlled by the European Commission continues to represent a leading end use sector for enzyme consumption. Increasing apprehensions related to the persisting contamination of the detergent chemicals in the ground water and environment along with various other health issues has raised speculations about the biodegradability of the product. Such factors continue to encourage application of the enzymes along with the surge in demand for the green cleaning detergents.

Request a report sample to gain comprehensive market insights @

https://www.futuremarketinsights.com/reports/sample/rep-gb-5619

Sales to Remain High in the Food Industry

Rapid advancements in the emerging enzyme technology has led to surge in demand for microbial lipase globally. By source type, the microbial source segment is projected to represent a significant growth in terms of revenue, representing more than US$ 300 Mn by 2026-end. On the contrary, the animal source type segment is projected to reflect the highest CAGR through 2026.

On the basis of application, the food segment is projected to generate highest revenues, accounting for less than US$ 100 Mn by 2017-end. However, the animal feed application segment is projected to reflect a robust CAGR during the forecast period. Based on forms, the liquid segment is projected to represent a robust revenue growth, representing more than US$ 200 Mn by 2026-end. On the other hand, the powder form segment is projected to witness the fastest growth in the global market of lipase throughout 2026.

Contact Sales for Further Assistance in Purchasing this Report@ https://www.futuremarketinsights.com/checkout/5619

Market Players

Major players in the global market of lipase are Koninklijke DSM N.V., Novozymes A/S, Amano Enzymes Inc., Hansen Holdings A/S, E. I. Du Pont De Nemours and Company, Associated British Foods PLC, Clerici-Sacco Group, Advanced Enzymes, Enzyme Development Corporation and Renco New Zealand.

About Food Market Division at FMI

Expert analysis, actionable insights, and strategic recommendations – the food & beverage team at Future Market Insights helps clients from across the globe with their unique business intelligence needs. With a repertoire of over 1,000 reports and 1 million+ data points, the team has analysed the food & beverage industry lucidly in 50+ countries for over a decade. The team provides end-to-end research and consulting services; reach out to explore how we can help.

Organic Oats Market Outlook, Current and Future Industry Landscape Analysis 2027

A new research report by Future Market Insights titled “Organic Oats Market: Global Industry Analysis (2012-2016) and Opportunity Assessment (2017-2027)” covers the global market scenario of organic oats across regions such as North America, Latin America, Asia Pacific excluding Japan (APEJ), Western Europe, Eastern Europe, Japan and the Middle East and Africa (MEA). The global organic oats market witnessed fast growth since 2012 but was small in valuation. The positive growth graph of the market is attributed to several aspects that are discussed below. The detailed pricing analysis and value chain assessment is also covered in this research report. The market is segmented in-depth to gain complete understanding of the global market. This research report is focussed on the applications of organic oats, various product types of organic oats and distribution channels to reach various customers. The study incudes historic data of the organic oats market along with the current market scenario. Based on trends and developments and the historic and current market data, future market evaluation has been carried out for a period of 10 years.

Global Organic Oats Market: Forecast

The global organic oats market is expected to reach a value of a little under US$ 370 Mn by the end of 2027 from a value of about US$ 198 Mn in 2017. It is projected to grow at a robust value CAGR of 6.4% throughout the period of forecast, 2017-2027.

For Information On The Research Approach Used In The Report, Ask Analyst @ https://www.futuremarketinsights.com/ask-question/rep-gb-1692

Global Organic Oats Market: Segmental Highlights

The global organic oats market is segmented by application, by product type, by distribution channel and by region.

By application, breakfast cereals is the largest segment. This segment is estimated to reach a high valuation of more than US$ 180 Mn by 2027 end and is expected to grow at the fastest pace in the coming years.
By region, Western Europe is the largest regional market. The organic oats market in Western Europe is likely to dominate the global market during the forecast period. The organic oats market in North America is projected to grow at the fastest pace to register a stellar value CAGR of 7.1% during the forecast period.
By product type, the rolled oats segment is expected to dominate the global market in the coming years. This segment is also the fastest growing segment and is poised to reflect a CAGR of 6.7%.
By distribution channel, the hypermarket/supermarket segment is estimated to reach a valuation of about US$ 236 Mn and is the largest distribution channel segment by value.

Global Organic Oats Market: Factors Influencing Growth

Growing demand for organic food, growing consumer confidence towards organic food, growing retail chains offering organic products, increasing market penetration of organic food, improved retail formats, increasing per capita disposable income, emergence of modern trade and online retail formats and higher preference for premium products is contributing to the growth of the global organic oats market. Aspects such as a highly competitive market, lack of marketing standardisation and fluctuating input costs are pulling down the growth of the global organic oats market.

Request a report sample to gain comprehensive market insights @ https://www.futuremarketinsights.com/reports/sample/rep-gb-1692

Global Organic Oats Market: Competitive Assessment

The research report on the global organic oats market covers competitive assessment that includes profiles of companies such as Nature’s Path, Grain Millers, Inc., The Hain Celestial Group, Inc., Quaker Oats Company, Nairn’s Oatcakes Limited, NOW Health Group, Inc., Bagrry’s India Ltd., General Mills Inc., Helsinki Mills Ltd., Unigrain Pty Ltd., Bob’s Red Mill Natural Foods, Inc., GrandyOats, Richardson International Limited, Blue Lake Milling Pty Ltd., Avena Foods Limited, Morning Foods Limited, Annex Holdings Pty Ltd., The Jordans & Ryvita Company Ltd., E. Flahavan and Sons Limited and Willow Creek Organic Grain Co. Inc.

About Food Market Division at FMI

Chromatography Resin Market is expected to reach a valuation of US$ 2215 Million in 2031

ESOMAR-certified consulting firm Future Market Insights’ report projects the global chromatography resin market to rise at an impressive pace between 2021 and 2031. Growing adoption of affinity chromatography resin technology is expected to increase the demand of chromatography resins across the globe. Alongside this, increase in demand for monoclonal antibody production will improve the sales over the coming years.

Demand for chromatography resins is rising extensively within the biopharmaceutical companies and research institutes. Burgeoning adoption of synthetic chromatography resin for the separation of biosimilars and development of monoclonal antibodies will spur the growth.

As per the FMI’s analysis, affinity chromatography resin sales are set to grow at over 11.3% CAGR, to surpass a valuation of approx. US$ 879.6 Mn by 2031-end. However, stringent regulatory policies, availability of cost-effective alternatives, and high cost of the chromatography technologies are some of the factors limiting the market growth.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-1349

Increasing funding by governments and initiatives undertaken to curb the mortality rate due to non-communicable diseases will spur the adoption of chromatography resins across the globe. Also, increasing expenditure on the research & development of drug delivery among the industry giants will also boost the market demand.

According to the FMI’s analysis, the global chromatography resins market is anticipated to reach a valuation of nearly US$ 2215 Mn, registering a steady growth at 6.90% CAGR between 2021 and 2031.

Key Takeaways from FMI’s Chromatography Resin Market Study

In terms of product type, synthetic chromatography resins are anticipated to witness higher growth compared to the native chromatography resins
Affinity chromatography resin technology is expected to lead the segment, exhibiting the growth at 11.3% CAGR
Biopharmaceutical companies will remain the largest end-users of chromatography resins across the globe, surpassing valuation of approx. US$ 900 Mn by 2031-end
Rising government initiatives to curb the non-communicable diseases across India will spur the market demand
The U.S. is expected to remain the largest market of chromatography resins throughout the forecast period
Germany and the U.K, collectively, will lead the Europe’s chromatography resin market owing to the rising prevalence of non-communicable disease
China is anticipated to emerge as a potential market on the back of rising adoption of advanced chromatography technologies within the region

Competitive Landscape

Agilent Technologies, Bio-Rad Laboratories Inc., GE Healthcare, Waters Corporation, Expedeon Ltd., Thermo Fisher Scientific Inc., Pall Corporation, Merck KGaA, PerkinElmer Inc., Kaneka Corporation, Shimadzu Corporation, Knauer GmbH, Tosoch Bioscience, Avantor Performance Materials Inc., Mitsubishi Chemical Corporation, W.R. Grace & Co., JSR Micro Inc., and Life Technology Corporation among others are some key players operating in the chromatography resin market.

As per the FMI’s analysis, the market is dominated by top 5 players in the global chromatography resin market, accounting for over 70% of market share. Top 5 players include Bio-Rad Laboratories, Inc., GE Healthcare, Tosoh Corporation, Merck KGaA, and Thermo Fisher Scientific Inc.

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-1349

Why Future Market Insights?

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:

Contact Us:

Insoluble Dietary Fiber Market Outlook, Current and Future Industry Landscape Analysis 2027

Future Market Insights has analysed various facets of the global insoluble dietary fibre market from a global viewpoint and has sequentially arranged the statistical data in its new research publication titled “Insoluble Dietary Fibre Market: Global Industry Analysis (2012-2016) and Opportunity Assessment (2017-2027)”. The comprehensive research report on insoluble dietary fibre market uncovers various aspects of the global market that includes various trends, developments, drivers, restraints and opportunities across important regions in the globe. Extensive analysis on each segment of the market along with value and volume forecast projections portrays a realistic picture of the growth direction of the market that can assist the reader in deciding future moves and plan strategies.

To remain ‘ahead’ of your competitors, request for @

https://www.futuremarketinsights.com/reports/sample/rep-gb-624

Global Insoluble Dietary Fibre Market: Segmental Snapshot

The global insoluble dietary fibre market is segmented by product type, by application, by source and by region.

By region, North America is expected to show high attractiveness in the coming years. The insoluble dietary fibre market in this region is expected to reach a high value of about US$ 1.1 Bn by 2027 end and is likely to dominate the global market. Insoluble dietary fibre market in Asia Pacific excluding Japan (APEJ) region is projected to grow at the highest rate to reflect a CAGR of 7.0% throughout the period of forecast
By product type, cellulose segment is the largest and radiates high potential. It is projected to show fast pace and a compounded annual growth rate of 6.5% during 2017-2027. By the end of 2027, it is estimated at around US$ 1.6 Bn
By source, cereals and grains segment leads the global market. The fruits segment is poised to register a high CAGR of 6.2% during the period of assessment
By application, functional food and beverages segment reflects a revenue of around US$ 1 Bn in 2017. The pharmaceutical and dietary supplements segment in this category is the fastest growing segment in the coming years

Contact Sales for Further Assistance in Purchasing this Report@

https://www.futuremarketinsights.com/checkout/624

Global Insoluble Dietary Fibre Market: Forecast Analysis

The research report on global insoluble dietary fibres segment reflects growth opportunities for players involved in the market. According to this research, the global insoluble dietary fibre market is valued at US$ 1.6 Bn in 2017 and is estimated to reach US$ 2.9 Bn by the end of 2027, growing at a high 6.0% CAGR throughout the period of forecast.

Global Insoluble Dietary Fibre Market: Dynamics Impacting Growth

Various factors have an impact on the growth of the global market for insoluble dietary fibres. Aspects such as increasing awareness about the health benefits of dietary fibres, rising demand from diabetic patients, increasing use of insoluble dietary fibres in food fortification, increasing use of pectin in processing of food products, rising use of insoluble dietary fibres in animal feed, increasing consumption of functional food products, increasing consumer preference for encapsulated products, rising demand for beverages, increasing popularity of resistant starch, increasing investment in sports nutrition, rising expenditure on research and development and growing recognition of lignin are pushing the growth of the global insoluble dietary fibres market. However, factors like fluctuating input costs, stability challenges of encapsulates and side effects associated with excessive intake of insoluble dietary fibres are pulling the growth of the global market.

Global Insoluble Dietary Fibre Market: Competitive Assessment

The research report on global insoluble dietary fibres market includes detailed competitive analysis on major companies such as Ingredion Incorporated Chr. Hansen Holding A/S, Unipektin Ingredients AG, SunOpta, Inc., NEXIRA, E. I. du Pont de Nemours and Company, CP KELCO, Tate & Lyle PLC, Grain Processing Corporation, Cargill Incorporated, Archer Daniels Midland Company, TIC GUMS Inc., Rettenmaier & Söhne GmbH Co. KG, Roquette Frères, Barndad Nutrition, Südzucker Ag, Emsland-Group and International Fiber Corporation.

Oxytocic Pharmaceuticals Market is expected to reach US$ 207.80 Million by 2031

Future Market Insights’ published report on the global oxytocic pharmaceuticals market estimates that the market, which is presently valued at US$ 62.2 million, will expand at an impressive 7.74% CAGR to reach US$ 207.80 million value by 2031-end. In the report, titled “Oxytocic Pharmaceuticals Market: Global Industry Analysis & Opportunity Assessment, 2021-2031,”

Though synthetic oxytocin is chemically equivalent to naturally-occurring oxytocin, their pharmaceutical functions for aiding women in labour are quite distinctive. Medical professionals from around the world will continue to recommend synthetic-based oxytocic pharmaceuticals over natural since oxytocic pharmaceuticals originating from synthetic sources can boost the momentum of decelerated labour by IV administration.

More than 90% of the global market revenues for oxytocic pharmaceuticals will be harvested from the sales of oxytocic pharmaceuticals originating from synthetic sources. By the end of 2031, an estimated US$ 207.80 million revenues will be emanated from the global sales of synthetic oxytocic pharmaceuticals.

Future Market Insights projects that the global market for oxytocic pharmaceuticals will remain highly fragmented due to higher prevalence of local players as opposed to multinationals and conglomerates. Nevertheless, global pharmaceutical industry leaders such as Pfizer Inc., Novartis AG, Baxter Healthcare Corporation, and Teva Pharmaceutical Industries Ltd. are also partaking in the global oxytocic pharmaceuticals market. Other leading manufacturers of oxytocic pharmaceuticals include Biofutura Pharma SpA, Ferring BV, and Fresenius Kabi AG.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-1445

Global Oxytocic Pharmaceuticals Market: Regional Analysis

The need for oxytocic pharmaceuticals in the world will always remain contingent to the rise in pregnancy incidences and birth rate. Various parts of the world exhibit diverse birth rate, which incidentally drives the growth of their oxytocic pharmaceuticals market, accordingly. In North America, oxytocic pharmaceuticals are majorly used for postpartum haemorrhage, which is one of the most-prominent indication among labouring women in the US and Canada.

However, China is expected to remain the largest market for oxytocic pharmaceuticals in the world. Considering the country’s exploding birth rate, China’s oxytocic pharmaceuticals market will be valued over US$ 55 million by 2031-end, expanding at 9.8% CAGR. In 2016, Japan’s oxytocic pharmaceuticals revenues amounted to an estimated US$ 1.7 million, while the oxytocic pharmaceuticals market in Asia-Pacific excluding Japan & China (APEJC) region has been estimated to account for nearly 20% of global revenues.

Global Oxytocic Pharmaceuticals Market: Research Highlights

Licensing agreements for development of newer oxytocic pharmaceuticals is rampantly boosting the global market revenues, profiting local players as well as industry leaders.
Surging prevalence of labour induction procedures for child births will continue promoting the use of oxytocic pharmaceuticals throughout the forecast period.
The global oxytocic pharmaceuticals revenues, however, are projected to witness an inhibited growth on the account of rising preference to alternative drugs such as magnesium sulphate and misoprostol.
India’s contribution to the APEJC oxytocic pharmaceuticals market is predicted to reach nearly 60% by the end of 2031.
More than 22,000 thousand units of oxytocic pharmaceuticals will be sold globally for treating labour arrest over the forecast period.
Hospitals will remain the largest end-user of oxytocic pharmaceuticals in the world, revenues from which will expand beyond 12% CAGR.
A majority of medical professionals in the world will recommend intravenous administration of oxytocic pharmaceuticals, accounting for more than two-third of global market revenues by the end of 2031.

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-1445

Why Future Market Insights?

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:

Contact Us:

Vegan Pasta Market Outlook, Current and Future Industry Landscape Analysis 2032

The vegan pasta market is on a pace to grow ~9% annually through 2032, propelled in bulk by the global rise in vegan and plant-based eating with astounding stats. Affluent millennial in particular has been the central driver of the worldwide shift away from consuming animal-based products – giving a boost to the demand for vegan pasta in the fast growing global F&B industry.

In 2019, worldwide sales of vegan pasta, contributed by both conventional and organic variants, are estimated to reach a value of ~US$ 136 Mn. Demand for conventional vegan pasta continues to ride on wider availability, and its relatively low cost has made it the product of choice among consumers.

To remain ‘ahead’ of your competitors, request for @

https://www.futuremarketinsights.com/reports/sample/rep-gb-10641

Key Takeaways from the Vegan Pasta Market Study

The steady demand for conventional vegan pasta is likely to suffer with upsurge in the popularity of organic food products.
Organic vegan pasta will fare much better in line with increased emphasis on good health and growing incidences of food adulteration.
Wheat has long remained the preferred source or primary ingredient for traditional pasta, and continues to capture substantial share in the new vegan pasta space.
Certain limitations or adverse effects of wheat including gluten intolerance are likely to compelled manufacturers to explore other sources to offer gluten-free options.
FMI reports that demand for legumes and fava beans as a source of vegan pasta will increase with striking CAGR of ~12% and ~14% respectively through 2032.
As compared to developing regions, the sales of vegan pasta are envisaged to be higher in the countries of North America and Europe.

“As the growth of vegan culture and vegetarianism is expected to be quite strong going forward, vegan pasta will go mainstream with manufacturers centering on extended portfolio and branding their products with nutritional and environmental benefits,” says the FMI analyst.

Product Innovation Focused on Healthier and Sustainable Diets

The vegan pasta market is still at its infancy, with plenty of room for improvement. A variety of vegan pasta is likely to hit the shelves in the near future, as manufacturer prioritize ‘organic’ and ‘gluten-free’ aspects to ensure higher product quality and nutritional benefits.

Traditional pasta companies as well as many startups are set to capitalize on the steadily expanding market.
Barilla stays ahead in the game with the launch of one-ingredient legume pasta, made with just chickpeas and red lentils, in September 2021.

Veganism as a concept is practically unknown in remote areas and certain cities in developing countries, signifying a relatively low growth prospects of vegan pasta market in regions such as South Asia and Middle East & Africa. The scenario may change in the next ten years on the account of macro factors including internet penetration, which has been fueling the unification of media and food culture.

Contact Sales for Further Assistance in Purchasing this Report@

https://www.futuremarketinsights.com/checkout/10641

Find More Valuable Insights on Vegan Pasta Market

Future Market Insights, in its new offering, brings to fore an unbiased analysis of the global vegan pasta market, presenting historical demand data (2017-2021) and forecast statistics for the period, 2022-2032.

The study divulges compelling insights on the vegan pasta market on the basis of category (fresh and dried), nature (organic and conventional), source (wheat, rice, legumes, buckwheat, oats, and others), product (penne, spaghetti, elbows, fettuccine & linguine, and filled pasta), packaging (boxes, trays, packets, and pouches), and distribution channel (direct and indirect) across seven major regions.

About Food Market Division at FMI